Kerecis

Kerecis

Herstellung medizinischer Geräte

Isafjordur, Vestfirdir 18.660 Follower:innen

Kerecis is pioneering the use of fish skin and fatty-acids in the cellular therapy and regenerative medicine market.

Info

Kerecis was founded by Fertram Sigurjonsson around the concept of using fish skin to heal damaged tissue. The company is pioneering the use of fish skin and fatty acids in the globally expanding cellular therapy and regenerative medicine market. The fatty-acid rich (including Omega3) products from the company's patented technologies enable the body to regenerate tissues, rather than simply repair them and risk scarring. The Kerecis products are used to regenerate tissue in trauma and chronic wounds such as burns and diabetic wounds. Kerecis is also developing products for areas such as oral surgery, plastic surgery and neurological applications. The vision of Kerecis is to extend human life by supporting the body’s own ability to regenerate. The Kerecis mission is to become the world leader in regenerating damage of the human body by sustainably harnessing nature’s own remedies. In August 2023 Kerecis became Iceland’s first Unicorn when it sold to the Danish company Coloplast for $1.3 Billion.

Branche
Herstellung medizinischer Geräte
Größe
501–1.000 Beschäftigte
Hauptsitz
Isafjordur, Vestfirdir
Art
Privatunternehmen
Gegründet
2011
Spezialgebiete
Woundcare, Burn, Surgical, Regenerative Medicine, Dental, Biotechnology, Omega-3 und Fish-skin

Orte

Beschäftigte von Kerecis

Updates

Ähnliche Seiten

Finanzierung

Kerecis Insgesamt 21 Finanzierungsrunden

Letzte Runde

Serie D

60.000.000,00 $

Weitere Informationen auf Crunchbase